γδ T cell clonal proliferation early after PD-1 blockade

Koya Ono; Yasushi Onishi; Masahiro Kobayashi; Shunsuke Hatta; Kentaro Nasu; Shotaro Watanabe; Satoshi Ichikawa; Yoko Okitsu; Noriko Fukuhara; Hideo Harigae

doi:10.1007/s00277-018-3406-6

γδ T cell clonal proliferation early after PD-1 blockade

Ann Hematol. 2019 Jan;98(1):219-220. doi: 10.1007/s00277-018-3406-6. Epub 2018 Jun 26.

Authors

Affiliations

¹ Department of Hematology and Rheumatology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
² Department of Hematology and Rheumatology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. yonishi@med.tohoku.ac.jp.

PMID: 29946908
DOI: 10.1007/s00277-018-3406-6

No abstract available

Keywords: Classical Hodgkin lymphoma; Hemophagocytic lymphohistiocytosis; Hepatosplenic T cell lymphoma; Nivolumab; Programmed death 1; γδ T cell.

Publication types

Case Reports
Letter

MeSH terms

Aged
Cell Proliferation / drug effects*
Hodgkin Disease / drug therapy*
Hodgkin Disease / metabolism*
Hodgkin Disease / pathology
Humans
Male
Nivolumab / administration & dosage
Nivolumab / adverse effects*
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Receptors, Antigen, T-Cell, gamma-delta*
T-Lymphocytes / metabolism*
T-Lymphocytes / pathology

Substances

PDCD1 protein, human
Programmed Cell Death 1 Receptor
Receptors, Antigen, T-Cell, gamma-delta
Nivolumab